Monday, October 16, 2017 12:18 AM
(NYSE: AGN) and its subsidiaries announced Thursday that the company has reached an agreement with InnoPharma Inc. resolving patent litigation regarding U.S. patents covering its Restasis dry eye drug, which are Orange book-listed and will expire on August 27, 2024.
Wednesday, September 27, 2017 12:27 AM
announced that it has acquired Unified Imaging
, an image management software solution that delivers a cloud-based system for image display, review and comparisons, as well as an interface with most image-producing devices that export ophthalmic instrument images.
Friday, September 15, 2017 12:15 AM
NILES, Ill. and BIRMINGHAM, Mich.—M&S Technologies
and MacuHealth, LP
have entered into a cooperative marketing agreement. The two companies issued a statement saying they will educate and train eyecare professionals on the direct relationship between enriching macular pigment with nutritional supplements and optimizing visual performance.
Wednesday, August 23, 2017 12:30 AM
DUBLIN, Calif. and JENA, Germany—Zeiss
has acquired Veracity Innovations, a medical software company in Temple, Texas. The purchase price was not disclosed.
Friday, July 28, 2017 12:18 AM
MEMPHIS, Tenn.—Southern College of Optometry
is opening FocalPoint, the first facility of its kind in the U.S. to offer completely paperless telemedicine via EyecareLive
Friday, July 21, 2017 12:23 AM
HARRISBURG, Pa.—The Life Sciences Greenhouse of Central Pennsylvania
(LSGPA) has invested an additional $500,000 in MacuLogix, a company that equips eyecare professionals with the instruments, tools and education needed to effectively manage patients with Age-related Macular Degeneration (AMD).
Monday, July 17, 2017 12:24 AM
SYLMAR, Calif.—Second Sight Medical Products
(NASDAQ:EYES) recently announced that its Argus II Retinal Prosthesis System can now be covered by Medicare in seven of the 12 Medicare Administrative Contractor (“MAC”) jurisdictions nationwide, representing a total of 28 states, two territories, and the District of Columbia.
Friday, June 30, 2017 12:15 AM
HEIDELBERG, Germany—Novaliq GmbH
, a Heidelberg-based specialty pharmaceutical company focused on ophthalmology, has appointed Gabriela Burian, MD, MPH, as chief medical officer. She will report to the company’s managing director and CEO, Christian Roesky, PhD.
Wednesday, June 28, 2017 12:27 AM
GRAND RAPIDS, Mich.—Grand Rapids Ophthalmology
(GRO) has appointed Roger J. Valine to its board of directors and he will serve as chairman.
Monday, June 26, 2017 12:21 AM
, a Waltham, Mass.-based ophthalmic pharmaceutical and medical device company specializing in corneal remodeling, has appointed Thomas E. Griffin as chief financial officer.
Wednesday, June 21, 2017 12:15 AM
announced this week that John Snisarenko has been named group vice president and head of ophthalmics U.S. franchise.
Friday, June 9, 2017 12:27 AM
NEW BRUNSWICK, N.J.—Johnson & Johnson Vision Care
has named Dr. Jonathan Talamo as its new chief medical officer (CMO) and worldwide vice president of medical affairs and clinical affairs for Johnson & Johnson Vision, which comprises both its vision care and surgical businesses.
Monday, June 5, 2017 12:24 AM
OPHIA ANTIPOLIS, France—Nicox S.A.
(Euronext Paris: FR0013018124, COX), an ophthalmic research and discovery company, has announced that the Food and Drug Administration (FDA) has approved its new drug Zerviate (cetirizine ophthalmic solution 0.24%), the first topical ocular formulation of this antihistamine.